(VIV) Vivendi - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000127771
Games, Music, Telecom, Content, Media
VIV EPS (Earnings per Share)
VIV Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.5% |
| Value at Risk 5%th | 39.5% |
| Relative Tail Risk | -15.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -72.61 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.574 |
| Beta | 0.238 |
| Beta Downside | 0.133 |
| Drawdowns 3y | |
|---|---|
| Max DD | 83.60% |
| Mean DD | 29.11% |
| Median DD | 14.34% |
Description: VIV Vivendi November 09, 2025
Vivendi SE (ticker VIV) is a diversified French conglomerate active across content, media, and entertainment, operating in Europe, the Americas, Asia/Oceania, and Africa. Its portfolio spans digital gaming (mobile, PC, console), recorded music and publishing, audio-visual production, online sports betting, fixed-line and mobile connectivity, and digital services for residential and business customers, plus education and news content in Spanish- and Portuguese-speaking markets.
Key recent metrics: 2023 revenue was €57 billion, with the telecom arm (Free) contributing roughly 30% and the media & content segment about 25%; EBITDA margin hovered near 12%, reflecting pressure from high-capex telecom investments and slower ad-spending growth in Europe. The global gaming market is projected to expand at ~9% CAGR through 2027, a tailwind for Vivendi’s gaming initiatives, while regulatory scrutiny of online betting in Europe adds a layer of operational risk.
If you want a data-rich, side-by-side comparison of Vivendi’s valuation drivers versus peers, the ValueRay platform offers a granular, up-to-date dashboard that can help you test these assumptions further.
VIV Stock Overview
| Market Cap in USD | 3,594m |
| Sub-Industry | Movies & Entertainment |
| IPO / Inception | |
| Return 12m vs S&P 500 | -71.7% |
| Analyst Rating | - |
VIV Dividends
| Dividend Yield | 1.37% |
| Yield on Cost 5y | 0.45% |
| Yield CAGR 5y | -19.66% |
| Payout Consistency | 80.3% |
| Payout Ratio | 65.8% |
VIV Growth Ratios
| CAGR 3y | -29.95% |
| CAGR/Max DD Calmar Ratio | -0.36 |
| CAGR/Mean DD Pain Ratio | -1.03 |
| Current Volume | 1137.1k |
| Average Volume | 1238.8k |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-6.05b TTM) > 0 and > 6% of Revenue (6% = 280.3m TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -3.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -7.39% (prev -29.05%; Δ 21.66pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.24 (>3.0%) and CFO 1.78b > Net Income -6.05b (YES >=105%, WARN >=100%) |
| Net Debt (1.82b) to EBITDA (371.0m) ratio: 4.91 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (996.1m) change vs 12m ago -2.54% (target <= -2.0% for YES) |
| Gross Margin 48.32% (prev 46.89%; Δ 1.42pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 20.10% (prev 32.41%; Δ -12.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.40 (EBITDA TTM 371.0m / Interest Expense TTM 211.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.05
| (A) -0.05 = (Total Current Assets 363.0m - Total Current Liabilities 708.0m) / Total Assets 7.33b |
| (B) 0.52 = Retained Earnings (Balance) 3.79b / Total Assets 7.33b |
| (C) -0.02 = EBIT TTM -507.0m / Avg Total Assets 23.24b |
| (D) 1.74 = Book Value of Equity 4.36b / Total Liabilities 2.51b |
| Total Rating: 3.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 25.21
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield -1.34% = -0.67 |
| 3. FCF Margin -1.41% = -0.53 |
| 4. Debt/Equity 0.41 = 2.42 |
| 5. Debt/Ebitda 4.91 = -2.50 |
| 6. ROIC - WACC (= -11.45)% = -12.50 |
| 7. RoE -128.7% = -2.50 |
| 8. Rev. Trend -60.72% = -4.55 |
| 9. EPS Trend -39.10% = -1.95 |
What is the price of VIV shares?
As of November 15, 2025, the stock is trading at EUR 2.92 with a total of 1,137,105 shares traded.
Over the past week, the price has changed by -1.68%, over one month by -2.73%, over three months by -7.62% and over the past year by -67.57%.
Over the past week, the price has changed by -1.68%, over one month by -2.73%, over three months by -7.62% and over the past year by -67.57%.
Is Vivendi a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, Vivendi (PA:VIV) is currently (November 2025)
a stock to sell. It has a ValueRay Fundamental Rating of 25.21 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VIV is around 2.13 EUR . This means that VIV is currently overvalued and has a potential downside of -27.05%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VIV is around 2.13 EUR . This means that VIV is currently overvalued and has a potential downside of -27.05%.
Is VIV a buy, sell or hold?
Vivendi has no consensus analysts rating.
What are the forecasts/targets for the VIV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.6 | 22.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.3 | -21.2% |
VIV Fundamental Data Overview January 01, 1970
Market Cap USD = 3.59b (3.10b EUR * 1.159 EUR.USD)
Market Cap EUR = 3.10b (3.10b EUR * 1.0 EUR.EUR)
P/E Forward = 10.8696
P/S = 10.0691
P/B = 0.6183
P/EG = 1.6331
Beta = 1.243
Revenue TTM = 4.67b EUR
EBIT TTM = -507.0m EUR
EBITDA TTM = 371.0m EUR
Long Term Debt = 1.50b EUR (from longTermDebt, last quarter)
Short Term Debt = 474.0m EUR (from shortTermDebt, last quarter)
Debt = 1.99b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b EUR (from netDebt column, last quarter)
Enterprise Value = 4.93b EUR (3.10b + Debt 1.99b - CCE 167.0m)
Interest Coverage Ratio = -2.40 (Ebit TTM -507.0m / Interest Expense TTM 211.0m)
FCF Yield = -1.34% (FCF TTM -66.0m / Enterprise Value 4.93b)
FCF Margin = -1.41% (FCF TTM -66.0m / Revenue TTM 4.67b)
Net Margin = -129.6% (Net Income TTM -6.05b / Revenue TTM 4.67b)
Gross Margin = 48.32% ((Revenue TTM 4.67b - Cost of Revenue TTM 2.41b) / Revenue TTM)
Gross Margin QoQ = 30.34% (prev 30.34%)
Tobins Q-Ratio = 0.67 (Enterprise Value 4.93b / Total Assets 7.33b)
Interest Expense / Debt = 3.11% (Interest Expense 62.0m / Debt 1.99b)
Taxrate = 14.29% (2.50m / 17.5m)
NOPAT = -434.6m (EBIT -507.0m * (1 - 14.29%)) [loss with tax shield]
Current Ratio = 0.51 (Total Current Assets 363.0m / Total Current Liabilities 708.0m)
Debt / Equity = 0.41 (Debt 1.99b / totalStockholderEquity, last quarter 4.82b)
Debt / EBITDA = 4.91 (Net Debt 1.82b / EBITDA 371.0m)
Debt / FCF = -27.59 (negative FCF - burning cash) (Net Debt 1.82b / FCF TTM -66.0m)
Total Stockholder Equity = 4.70b (last 4 quarters mean from totalStockholderEquity)
RoA = -82.62% (Net Income -6.05b / Total Assets 7.33b)
RoE = -128.7% (Net Income TTM -6.05b / Total Stockholder Equity 4.70b)
RoCE = -8.18% (EBIT -507.0m / Capital Employed (Equity 4.70b + L.T.Debt 1.50b))
RoIC = -6.21% (negative operating profit) (NOPAT -434.6m / Invested Capital 7.00b)
WACC = 5.24% (E(3.10b)/V(5.09b) * Re(6.89%) + D(1.99b)/V(5.09b) * Rd(3.11%) * (1-Tc(0.14)))
Discount Rate = 6.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -4.97%
Fair Price DCF = unknown (Cash Flow -66.0m)
EPS Correlation: -39.10 | EPS CAGR: 9.72% | SUE: 0.11 | # QB: 0
Revenue Correlation: -60.72 | Revenue CAGR: -78.35% | SUE: 0.01 | # QB: 0
Market Cap EUR = 3.10b (3.10b EUR * 1.0 EUR.EUR)
P/E Forward = 10.8696
P/S = 10.0691
P/B = 0.6183
P/EG = 1.6331
Beta = 1.243
Revenue TTM = 4.67b EUR
EBIT TTM = -507.0m EUR
EBITDA TTM = 371.0m EUR
Long Term Debt = 1.50b EUR (from longTermDebt, last quarter)
Short Term Debt = 474.0m EUR (from shortTermDebt, last quarter)
Debt = 1.99b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b EUR (from netDebt column, last quarter)
Enterprise Value = 4.93b EUR (3.10b + Debt 1.99b - CCE 167.0m)
Interest Coverage Ratio = -2.40 (Ebit TTM -507.0m / Interest Expense TTM 211.0m)
FCF Yield = -1.34% (FCF TTM -66.0m / Enterprise Value 4.93b)
FCF Margin = -1.41% (FCF TTM -66.0m / Revenue TTM 4.67b)
Net Margin = -129.6% (Net Income TTM -6.05b / Revenue TTM 4.67b)
Gross Margin = 48.32% ((Revenue TTM 4.67b - Cost of Revenue TTM 2.41b) / Revenue TTM)
Gross Margin QoQ = 30.34% (prev 30.34%)
Tobins Q-Ratio = 0.67 (Enterprise Value 4.93b / Total Assets 7.33b)
Interest Expense / Debt = 3.11% (Interest Expense 62.0m / Debt 1.99b)
Taxrate = 14.29% (2.50m / 17.5m)
NOPAT = -434.6m (EBIT -507.0m * (1 - 14.29%)) [loss with tax shield]
Current Ratio = 0.51 (Total Current Assets 363.0m / Total Current Liabilities 708.0m)
Debt / Equity = 0.41 (Debt 1.99b / totalStockholderEquity, last quarter 4.82b)
Debt / EBITDA = 4.91 (Net Debt 1.82b / EBITDA 371.0m)
Debt / FCF = -27.59 (negative FCF - burning cash) (Net Debt 1.82b / FCF TTM -66.0m)
Total Stockholder Equity = 4.70b (last 4 quarters mean from totalStockholderEquity)
RoA = -82.62% (Net Income -6.05b / Total Assets 7.33b)
RoE = -128.7% (Net Income TTM -6.05b / Total Stockholder Equity 4.70b)
RoCE = -8.18% (EBIT -507.0m / Capital Employed (Equity 4.70b + L.T.Debt 1.50b))
RoIC = -6.21% (negative operating profit) (NOPAT -434.6m / Invested Capital 7.00b)
WACC = 5.24% (E(3.10b)/V(5.09b) * Re(6.89%) + D(1.99b)/V(5.09b) * Rd(3.11%) * (1-Tc(0.14)))
Discount Rate = 6.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -4.97%
Fair Price DCF = unknown (Cash Flow -66.0m)
EPS Correlation: -39.10 | EPS CAGR: 9.72% | SUE: 0.11 | # QB: 0
Revenue Correlation: -60.72 | Revenue CAGR: -78.35% | SUE: 0.01 | # QB: 0